NDC 68001-371

Cyclophosphamide

Cyclophosphamide

Cyclophosphamide is a Intravenous; Oral Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Bluepoint Laboratories. The primary component is Cyclophosphamide.

Product ID68001-371_29c43047-dc57-401f-9433-d30685a1e134
NDC68001-371
Product TypeHuman Prescription Drug
Proprietary NameCyclophosphamide
Generic NameCyclophosphamide
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAVENOUS; ORAL
Marketing Start Date2018-05-31
Marketing CategoryANDA / ANDA
Application NumberANDA210046
Labeler NameBluePoint Laboratories
Substance NameCYCLOPHOSPHAMIDE
Active Ingredient Strength1 g/50mL
Pharm ClassesAlkylating Activity [MoA],Alkylating Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68001-371-32

1 VIAL, SINGLE-DOSE in 1 CARTON (68001-371-32) > 50 mL in 1 VIAL, SINGLE-DOSE (68001-371-33)
Marketing Start Date2018-11-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68001-371-32 [68001037132]

Cyclophosphamide INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA210046
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-11-23

NDC 68001-371-33 [68001037133]

Cyclophosphamide INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA210046
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-05-31

Drug Details

Active Ingredients

IngredientStrength
CYCLOPHOSPHAMIDE1 g/50mL

OpenFDA Data

SPL SET ID:457ede7d-d2f9-49a3-9de7-651f64a210e1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1734921
  • 1734919
  • 1734917
    • UPC Code
  • 0368001371339
  • 0368001372336
  • 0368001370240

    • Pharmacological Class

    • Alkylating Activity [MoA]
    • Alkylating Drug [EPC]

    NDC Crossover Matching brand name "Cyclophosphamide" or generic name "Cyclophosphamide"

    NDCBrand NameGeneric Name
    0054-0382CyclophosphamideCyclophosphamide
    0054-0383CyclophosphamideCyclophosphamide
    0781-3233Cyclophosphamidecyclophosphamide
    0781-3244Cyclophosphamidecyclophosphamide
    0781-3255Cyclophosphamidecyclophosphamide
    10019-935CYCLOPHOSPHAMIDEcyclophosphamide
    10019-936CYCLOPHOSPHAMIDEcyclophosphamide
    10019-937CYCLOPHOSPHAMIDEcyclophosphamide
    10019-938CYCLOPHOSPHAMIDEcyclophosphamide
    10019-939CYCLOPHOSPHAMIDEcyclophosphamide
    10019-942CYCLOPHOSPHAMIDEcyclophosphamide
    10019-943CYCLOPHOSPHAMIDEcyclophosphamide
    10019-944CYCLOPHOSPHAMIDEcyclophosphamide
    68001-370CyclophosphamideCyclophosphamide
    68001-372CyclophosphamideCyclophosphamide
    68001-371CyclophosphamideCyclophosphamide
    69097-516CyclophosphamideCyclophosphamide
    69097-517CyclophosphamideCyclophosphamide
    70121-1239CyclophosphamideCyclophosphamide
    70121-1240CyclophosphamideCyclophosphamide
    70121-1238CyclophosphamideCyclophosphamide
    10019-955CyclophosphamideCyclophosphamide
    10019-988CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    10019-957CyclophosphamideCyclophosphamide
    10019-989CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    10019-990CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    10019-945CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    10019-956CyclophosphamideCyclophosphamide
    16714-859CyclophosphamideCyclophosphamide
    16714-857CyclophosphamideCyclophosphamide
    16714-858CyclophosphamideCyclophosphamide
    43975-308CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    43975-307CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    54879-022CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    54879-021CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    72603-411CyclophosphamideCyclophosphamide
    72603-104CyclophosphamideCyclophosphamide
    72603-326CyclophosphamideCyclophosphamide
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.